Want to join the conversation?
Genetic testing tools company $ILMN reported a rise in 2Q16 earnings driven by notable strength across its sequencing consumable and array portfolios. Net income rose to $121.97MM or $0.82 per share from $102.25MM or $0.69 per share last year. Revenue grew to $600.12MM from $539.38MM. Non-GAAP EPS increased to $0.86 from $0.80.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.